Chair
Department of Neurosurgery, University of Tennessee Health Sciences Center
Memphis, Tennessee, United States
Dr Arthur is the James T. Robertson Professor and Chair of the Department of Neurosurgery at the University of Tennessee Health Sciences Center and Semmes-Murphey Clinic. This is one of the largest and busiest practices in the country. His individual practice is focused on comprehensive treatment for patients with cerebrovascular disease. Dr Arthur has led several large multicenter clinical trials focused on new treatments for hemorrhagic and ischemic stroke patients and is commited to providing exceptional training for residents and fellows.
(PC1102) Practical Clinic: How to Apply to Residency
Thursday, April 20, 2023
1:30pm – 5:00pm PST
Disclosure(s): Arsenal Medical: Consultant (Ongoing); Balt: Consultant (Ongoing), Grant/Research Support (Ongoing); Bend IT Technologies, Ltd.: Stock Shareholder (excluding mutual funds) (Ongoing); Cerebrotech: Ownership Interest (Ongoing); Cerenovus: Consultant (Ongoing); Endostream Medical : Ownership Interest (Ongoing); Magneto: Stock Shareholder (excluding mutual funds) (Ongoing); Medtronic: Consultant (Ongoing), Grant/Research Support (Ongoing); Mentice: Stock Shareholder (excluding mutual funds) (Ongoing); Microvention: Consultant (Ongoing), Grant/Research Support (Ongoing); Neurogami: Stock Shareholder (excluding mutual funds) (Ongoing); Neuros Medical: Stock Shareholder (excluding mutual funds) (Ongoing); Penumbra: Consultant (Ongoing), Grant/Research Support (Ongoing); Perfuze: Consultant (Ongoing), Ownership Interest (Ongoing); RevBio: Stock Shareholder (excluding mutual funds) (Ongoing); Scientia: Consultant (Ongoing), Ownership Interest (Ongoing); Serenity Medical, Inc: Stock Shareholder (excluding mutual funds) (Ongoing); Siemens: Consultant (Ongoing), Grant/Research Support (Ongoing); Stryker Neurovascular: Consultant (Ongoing), Grant/Research Support (Ongoing); Synchron Inc: Stock Shareholder (excluding mutual funds) (Ongoing); Tulavi Therapeutics, Inc.: Stock Shareholder (excluding mutual funds) (Ongoing); Vastrax, LLC: Stock Shareholder (excluding mutual funds) (Ongoing); Viz.ai, Inc.: Stock Shareholder (excluding mutual funds) (Ongoing)
(OS) Introduction: Rhoton Family Lecture
Friday, April 21, 2023
5:03pm – 5:05pm PST
Disclosure(s): Arsenal Medical: Consultant (Ongoing); Balt: Consultant (Ongoing), Grant/Research Support (Ongoing); Bend IT Technologies, Ltd.: Stock Shareholder (excluding mutual funds) (Ongoing); Cerebrotech: Ownership Interest (Ongoing); Cerenovus: Consultant (Ongoing); Endostream Medical : Ownership Interest (Ongoing); Magneto: Stock Shareholder (excluding mutual funds) (Ongoing); Medtronic: Consultant (Ongoing), Grant/Research Support (Ongoing); Mentice: Stock Shareholder (excluding mutual funds) (Ongoing); Microvention: Consultant (Ongoing), Grant/Research Support (Ongoing); Neurogami: Stock Shareholder (excluding mutual funds) (Ongoing); Neuros Medical: Stock Shareholder (excluding mutual funds) (Ongoing); Penumbra: Consultant (Ongoing), Grant/Research Support (Ongoing); Perfuze: Consultant (Ongoing), Ownership Interest (Ongoing); RevBio: Stock Shareholder (excluding mutual funds) (Ongoing); Scientia: Consultant (Ongoing), Ownership Interest (Ongoing); Serenity Medical, Inc: Stock Shareholder (excluding mutual funds) (Ongoing); Siemens: Consultant (Ongoing), Grant/Research Support (Ongoing); Stryker Neurovascular: Consultant (Ongoing), Grant/Research Support (Ongoing); Synchron Inc: Stock Shareholder (excluding mutual funds) (Ongoing); Tulavi Therapeutics, Inc.: Stock Shareholder (excluding mutual funds) (Ongoing); Vastrax, LLC: Stock Shareholder (excluding mutual funds) (Ongoing); Viz.ai, Inc.: Stock Shareholder (excluding mutual funds) (Ongoing)
Saturday, April 22, 2023
9:50am – 9:54am PST
Disclosure(s): Arsenal Medical: Consultant (Ongoing); Balt: Consultant (Ongoing), Grant/Research Support (Ongoing); Bend IT Technologies, Ltd.: Stock Shareholder (excluding mutual funds) (Ongoing); Cerebrotech: Ownership Interest (Ongoing); Cerenovus: Consultant (Ongoing); Endostream Medical : Ownership Interest (Ongoing); Magneto: Stock Shareholder (excluding mutual funds) (Ongoing); Medtronic: Consultant (Ongoing), Grant/Research Support (Ongoing); Mentice: Stock Shareholder (excluding mutual funds) (Ongoing); Microvention: Consultant (Ongoing), Grant/Research Support (Ongoing); Neurogami: Stock Shareholder (excluding mutual funds) (Ongoing); Neuros Medical: Stock Shareholder (excluding mutual funds) (Ongoing); Penumbra: Consultant (Ongoing), Grant/Research Support (Ongoing); Perfuze: Consultant (Ongoing), Ownership Interest (Ongoing); RevBio: Stock Shareholder (excluding mutual funds) (Ongoing); Scientia: Consultant (Ongoing), Ownership Interest (Ongoing); Serenity Medical, Inc: Stock Shareholder (excluding mutual funds) (Ongoing); Siemens: Consultant (Ongoing), Grant/Research Support (Ongoing); Stryker Neurovascular: Consultant (Ongoing), Grant/Research Support (Ongoing); Synchron Inc: Stock Shareholder (excluding mutual funds) (Ongoing); Tulavi Therapeutics, Inc.: Stock Shareholder (excluding mutual funds) (Ongoing); Vastrax, LLC: Stock Shareholder (excluding mutual funds) (Ongoing); Viz.ai, Inc.: Stock Shareholder (excluding mutual funds) (Ongoing)